Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hinton

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Eclinicalmedicine|February 2, 2024
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional studyAnna K Forbes, William Hinton, Michael D Feher, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
The Lancet. Public Health|July 30, 2025
Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort studyBernardo Meza-Torres, Gavin Jamie, Rashmi Wimalaratna, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2024
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care populationAnna K Forbes, William Hinton, Michael D Feher, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 23, 2021
Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary careMichelle Greiver, Alys Havard, Juliana Kf Bowles, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 11, 2025
Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022José M Ordóñez-Mena, Xinchun Gu, Mark Joy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Mark Joy, Rachel Byford, et al.
Journal of the Royal Society of Medicine|November 3, 2023
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Utkarsh Agrawal, Mark Joy, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Eclinicalmedicine|February 2, 2024
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional studyAnna K Forbes, William Hinton, Michael D Feher, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
The Lancet. Public Health|July 30, 2025
Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort studyBernardo Meza-Torres, Gavin Jamie, Rashmi Wimalaratna, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2024
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care populationAnna K Forbes, William Hinton, Michael D Feher, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 23, 2021
Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary careMichelle Greiver, Alys Havard, Juliana Kf Bowles, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 11, 2025
Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022José M Ordóñez-Mena, Xinchun Gu, Mark Joy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Mark Joy, Rachel Byford, et al.
Journal of the Royal Society of Medicine|November 3, 2023
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Utkarsh Agrawal, Mark Joy, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
Pageof 6